These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4755498)

  • 1. Editorial: Is the FDA too fearsome?
    Berry FB
    Med Times; 1973 Oct; 101(10):15 passim. PubMed ID: 4755498
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Some caveats for the FDA.
    Calif Med; 1973 Oct; 119(4):64-5. PubMed ID: 4749314
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: The FDA and the supreme court.
    Dornette WH
    J Indiana State Med Assoc; 1974 Feb; 67(2):121-2. PubMed ID: 4812470
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: FDA--approved?
    Collins CM
    J Fla Med Assoc; 1974 Jun; 61(6):458-9. PubMed ID: 4831239
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: The FDA reversed.
    Davis CE
    Va Med Mon (1918); 1974 Jan; 101(1):15-6. PubMed ID: 4809396
    [No Abstract]   [Full Text] [Related]  

  • 6. Critics fear the FDA is going too far in cutting industry's regulatory load.
    Demkovich LE
    Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A visit from the FDA.
    Brett J
    J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA announces four initiatives for drug approval system.
    Clin Pharm; 1992 Jul; 11(7):574, 576. PubMed ID: 1617908
    [No Abstract]   [Full Text] [Related]  

  • 10. Criteria for extra-label drug use debated at FDA Advisory Committee meeting.
    Raef TA
    J Am Vet Med Assoc; 1995 Jul; 207(1):10-1. PubMed ID: 7601683
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA issues requirement for retaining drug samples.
    Oncology (Williston Park); 1991 May; 5(5):176. PubMed ID: 1832001
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA backs legislation to restrict antimicrobial use.
    Cima G
    J Am Vet Med Assoc; 2009 Sep; 235(5):493-5. PubMed ID: 19731457
    [No Abstract]   [Full Text] [Related]  

  • 13. Sundlof outlines vision for FDA to council.
    J Am Vet Med Assoc; 1995 Feb; 206(3):275-6. PubMed ID: 7751227
    [No Abstract]   [Full Text] [Related]  

  • 14. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FDA--its role in testing.
    Minno AM
    Pa Med; 1971 Sep; 74(9):57-8. PubMed ID: 5095768
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives. Hitting the FDA ... again.
    Wiener JO
    Faulkner Grays Med Health; 1990 Oct; 44(41):suppl 4 p.. PubMed ID: 10107287
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA extra-label use policy: 1992 revisions.
    Guest GB; Solomon SM
    J Am Vet Med Assoc; 1993 May; 202(10):1620-3;discussion 1626-31. PubMed ID: 8514568
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Whither nuclear pharmacy?
    Robinson RG; Rhodes BA
    J Nucl Med; 1976 Jul; 17(7):577-8. PubMed ID: 1271103
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA under attack.
    Mod Vet Pract; 1981 Mar; 62(3):197-201. PubMed ID: 7207445
    [No Abstract]   [Full Text] [Related]  

  • 20. Current FDA policy on use of human-labeled drugs in animals.
    Teske RH
    J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.